Elliot Wakeam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Elliot Wakeam has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Jonathan Yeung
Division of Thoracic Surgery, Department of Surgery, University Health Network, Toronto, Canada
2 shared publications- Aadil Ali
Department of Surgery, Division of Thoracic Surgery, University of Toronto, Toronto, Canada
1 shared publication - Adom Bondzi-Simpson
Department of Surgery, University of Toronto, Toronto, Ontario, Canada
1 shared publication - Alberto Benazzo
Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria
1 shared publication - Alejandra Romero Román
Department of Thoracic Surgery, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain
1 shared publication Andreea Cristina Matei
Department of Surgery, University of Toronto, Toronto, Ontario, Canada
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 16 January 2025
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 281 (4) , 664-670
Prolonged Preservation of up to 24 Hours at 10 °C Does Not Impact Outcomes after Lung Transplantation
Objective: To determine the impact of prolonged storage of donor lungs at 10 °C for up to 24 hours on outcome after lung transplantation. Background: An increasing body of evidence suggests 10 °C as the optimal storage temperature for donor lungs. A recent study showed that cold ischemic times can be safely expanded to >12 hours when lungs are stored at 10 °C. However, it is currently unknown how long donor lungs can be preserved before they deteriorate in function. Methods: Patients who received a donor lung stored at 10 °C between November 2020 and June 2023 at the lung transplant programs of Toronto, Vienna, and Madrid were included in this retrospective analysis. After excluding ex-vivo lung perfusion cases, recipients were grouped based on the total preservation times of their donor organs (P = 0.493]. Intensive care unit length of stay [6 days (4–14); 8 days (4–23); 8 days (5–32)] and hospital length of stay [32 days (20–48); 29 days (20–50); 26 days (17–50)] were also similar. Furthermore, the length of donor organ preservation had no impact on patient survival (log-rank P = 0.413). Conclusions: Prolonged static preservation of donor lungs at 10 °C for up to 24 hours is safe and does not impair short-intermediate outcomes after lung transplantation.
- 16 January 2025
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 281 (4) , 664-670
Top Cited PapersOpen AccessProlonged Preservation of up to 24 Hours at 10 °C Does Not Impact Outcomes after Lung Transplantation
Objective: To determine the impact of prolonged storage of donor lungs at 10 °C for up to 24 hours on outcome after lung transplantation. Background: An increasing body of evidence suggests 10 °C as the optimal storage temperature for donor lungs. A recent study showed that cold ischemic times can be safely expanded to >12 hours when lungs are stored at 10 °C. However, it is currently unknown how long donor lungs can be preserved before they deteriorate in function. Methods: Patients who received a donor lung stored at 10 °C between November 2020 and June 2023 at the lung transplant programs of Toronto, Vienna, and Madrid were included in this retrospective analysis. After excluding ex-vivo lung perfusion cases, recipients were grouped based on the total preservation times of their donor organs (P = 0.493]. Intensive care unit length of stay [6 days (4–14); 8 days (4–23); 8 days (5–32)] and hospital length of stay [32 days (20–48); 29 days (20–50); 26 days (17–50)] were also similar. Furthermore, the length of donor organ preservation had no impact on patient survival (log-rank P = 0.413). Conclusions: Prolonged static preservation of donor lungs at 10 °C for up to 24 hours is safe and does not impair short-intermediate outcomes after lung transplantation.
- Open Access
- 16 November 2024
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (4) , 814-824
Prognostic implications of lung cancers incidentally identified on explant: A joint study of the Scientific Registry of Transplant Recipients and the National Cancer Database
- 16 November 2024
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (4) , 814-824
Open AccessPrognostic implications of lung cancers incidentally identified on explant: A joint study of the Scientific Registry of Transplant Recipients and the National Cancer Database
- Open Access
Exploring the landscape of oesophageal discontinuity procedures and creation of cervical oesophagostomy in the modern era: a scoping review protocol
Introduction Oesophageal discontinuity remains a challenge for thoracic and foregut surgeons globally. Whether arising emergently after catastrophic oesophageal or gastric disruption or arising in the elective setting in the case of staged reconstruction for esophagectomy or long gap atresia in the paediatric population, comprehensive review of this patient population remains unexplored within the surgical literature. The goal of this scoping review is to map the landscape of literature exploring the creation and takedown of cervical oesophagostomy with the intent to answer four questions (1) What are the primary indications for oesophageal discontinuity procedures? (2) What are the disease-specific and healthcare utilisation outcomes for oesophageal discontinuity procedures? (3) What is the primary indication for reversal procedures? (4) What are the disease-specific and healthcare utilisation outcomes for reversal procedures? Methods This review will follow the Arksey and O’Malley (2005) framework for scoping reviews. Paediatric (18 years old) patients, who have received a cervical oesophagostomy in the context of a gastrointestinal discontinuity procedure or those who have had reversal of a cervical oesophagostomy, will be included for analysis. We will search MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) databases for papers from 1990 until 2023. Interventional trials, prospective and retrospective observational studies, reviews, case series and qualitative study designs will be included. Two authors will independently review all titles, abstracts and full texts to determine which studies meet the inclusion criteria. Ethics and dissemination No ethics approval is required for this review. Results will be disseminated through scientific presentations and relevant conferences targeted for researchers examining upper gastrointestinal/foregut surgery. Registration details This protocol is registered with Open Science Framework (osf.io/s3b4g).
Open AccessExploring the landscape of oesophageal discontinuity procedures and creation of cervical oesophagostomy in the modern era: a scoping review protocol
Introduction Oesophageal discontinuity remains a challenge for thoracic and foregut surgeons globally. Whether arising emergently after catastrophic oesophageal or gastric disruption or arising in the elective setting in the case of staged reconstruction for esophagectomy or long gap atresia in the paediatric population, comprehensive review of this patient population remains unexplored within the surgical literature. The goal of this scoping review is to map the landscape of literature exploring the creation and takedown of cervical oesophagostomy with the intent to answer four questions (1) What are the primary indications for oesophageal discontinuity procedures? (2) What are the disease-specific and healthcare utilisation outcomes for oesophageal discontinuity procedures? (3) What is the primary indication for reversal procedures? (4) What are the disease-specific and healthcare utilisation outcomes for reversal procedures? Methods This review will follow the Arksey and O’Malley (2005) framework for scoping reviews. Paediatric (18 years old) patients, who have received a cervical oesophagostomy in the context of a gastrointestinal discontinuity procedure or those who have had reversal of a cervical oesophagostomy, will be included for analysis. We will search MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) databases for papers from 1990 until 2023. Interventional trials, prospective and retrospective observational studies, reviews, case series and qualitative study designs will be included. Two authors will independently review all titles, abstracts and full texts to determine which studies meet the inclusion criteria. Ethics and dissemination No ethics approval is required for this review. Results will be disseminated through scientific presentations and relevant conferences targeted for researchers examining upper gastrointestinal/foregut surgery. Registration details This protocol is registered with Open Science Framework (osf.io/s3b4g).
- 24 January 2024
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 118 (1) , 285-286
Postesophagectomy Complication Epidemiology: What Do We Really Know?
- 24 January 2024
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 118 (1) , 285-286
Postesophagectomy Complication Epidemiology: What Do We Really Know?
- 12 September 2023
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 116 (6) , 1168-1175
Epidemiology of Postoperative Complications After Esophagectomy: Implications for Management
- 12 September 2023
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 116 (6) , 1168-1175
Epidemiology of Postoperative Complications After Esophagectomy: Implications for Management
- 28 May 2023
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 42 (10) , 1425-1436
Lung transplantation for lung cancer: A systematic review of the literature
- 28 May 2023
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 42 (10) , 1425-1436
Lung transplantation for lung cancer: A systematic review of the literature